A comparative analysis of the aggregation behavior of amyloid-β peptide variants

被引：61

作者：

Vandersteen, Annelies ^{[1
,2
]}

Hubin, Ellen ^{[1
,3
,4
]}

Sarroukh, Rabia ^{[5
]}

De Baets, Greet ^{[2
]}

Schymkowitz, Joost ^{[2
]}

Rousseau, Frederic ^{[2
]}

Subramaniam, Vinod ^{[1
]}

Raussens, Vincent ^{[5
]}

Wenschuh, Holger ^{[6
]}

Wildemann, Dirk ^{[6
]}

Broersen, Kerensa ^{[1
]}

机构：

[1] Univ Twente, Nanobiophys Grp, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, NL-7500 AE Enschede, Netherlands

[2] Katholieke Univ Leuven KUL, VIB Switch Lab, Dept Cellular & Mol Med, B-3000 Louvain, Belgium

[3] Vrije Univ Brussel VUB, Dept Biotechnol DBIT, B-1050 Brussels, Belgium

[4] VIB Dept Struct Biol, B-1050 Brussels, Belgium

[5] Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, B-1050 Brussels, Belgium

[6] JPT Peptide Technol GmbH, D-12489 Berlin, Germany

来源：

FEBS LETTERS | 2012年 / 586卷 / 23期

关键词：

Thioflavin T fluorescence; Alzheimer's disease; FAD mutation; Biotinylation; p3; Peptide; Biophysics; TRANSMEMBRANE DOMAIN; ALZHEIMERS-DISEASE; PROTEIN; MUTATIONS; SECRETASE; CLEAVAGE; NEUROTOXICITY; PATHOGENESIS; DEGRADATION; PREDICTION;

D O I：

10.1016/j.febslet.2012.10.022

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Aggregated forms of the amyloid-beta peptide are hypothesized to act as the prime toxic agents in Alzheimer disease (AD). The in vivo amyloid-beta peptide pool consists of both C- and N-terminally truncated or mutated peptides, and the composition thereof significantly determines AD risk. Other variations, such as biotinylation, are introduced as molecular tools to aid the understanding of disease mechanisms. Since these modifications have the potential to alter key aggregation properties of the amyloid-beta peptide, we present a comparative study of the aggregation of a substantial set of the most common in vivo identified and in vitro produced amyloid-beta peptides.

引用

页码：4088 / 4093

页数：6

共 50 条

[1] Interfacial aggregation of amyloid-β peptide.
Nichols, MR
Rosenberry, TL
BIOCHEMISTRY, 2003, 42 (28) : 8645 - 8645
[2] Interfacial aggregation of amyloid-β peptide.
Nichols, MR
Rosenberry, TL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U188 - U188
[3] Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants
Tiwari, Manish K.
Kepp, Kasper P.
JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (01) : 215 - 229
[4] In vivo aggregation of β-amyloid peptide variants
Fay, DS
Fluet, A
Johnson, CJ
Link, CD
JOURNAL OF NEUROCHEMISTRY, 1998, 71 (04) : 1616 - 1625
[5] Amyloid-β peptide aggregation and the influence of carbon nanoparticles
Xi, Wen-Hui
Wei, Guang-Hong
CHINESE PHYSICS B, 2016, 25 (01)
[6] Amyloid-β peptide aggregation and the influence of carbon nanoparticles
郗文辉
韦广红
Chinese Physics B, 2016, (01) : 328 - 336
[7] Amyloid-β Peptide Interaction with Lipid Bilayer Promotes Peptide Aggregation on the Surface and Modulates Lipid Behavior
Usadi, Jacob
Vale, Arthur
Natesh, Sashin
Freed, Karl
Haddadian, Esmael
BIOPHYSICAL JOURNAL, 2018, 114 (03) : 429A - 430A
[8] Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
Braun, Gabriel A.
Dear, Alexander J.
Sanagavarapu, Kalyani
Zetterberg, Henrik
Linse, Sara
CHEMICAL SCIENCE, 2022, 13 (08) : 2423 - 2439
[9] Amyloid-β aggregation
Finder, Verena H.
Glockshuber, Rudi
NEURODEGENERATIVE DISEASES, 2007, 4 (01) : 13 - 27
[10] Effects of Fatty Acids and Phospholipids on Amyloid-β (Aβ) Peptide Aggregation
Kumar, Amit
Rice, Rebakah
Lidell, Shiela A.
Paslay, Lea C.
Morgan, Sarah
Rangachari, Vijay
BIOPHYSICAL JOURNAL, 2010, 98 (03) : 459A - 459A

← 1 2 3 4 5 →